"Sleep Patterns and EEG Structure in Youth With Autism: Links With Behavior and Parental Stress"

NCT ID: NCT07122388

Last Updated: 2025-08-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

187 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-01

Study Completion Date

2025-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective observational study is designed to investigate sleep patterns, as well as both the macrostructure and microstructure of sleep, in a large cohort of children and adolescents diagnosed with Autism Spectrum Disorder (ASD). The study will utilize data derived from overnight polysomnographic recordings, providing objective and comprehensive measures of sleep architecture.

The sample consists of 187 patients, aged between 3 and 16 years, whose sleep data were collected over a ten-year period, from 2003 to 2013. In addition to polysomnographic parameters, the study will incorporate a wide range of behavioral and parental stress-related variables. These will be assessed using validated, standardized instruments, including the Sleep Disturbance Scale for Children (SDSC), Autism Diagnostic Interview-Revised (ADI-R), Autism Diagnostic Observation Schedule-2 (ADOS-2), Child Behavior Checklist (CBCL), and the Parenting Stress Index - Short Form (PSI-SF).

By integrating objective sleep data with behavioral and psychosocial measures, this study aims to provide a more nuanced understanding of the nature and extent of sleep disturbances in individuals with ASD. Particular attention will be paid to identifying potential correlations between specific sleep alterations (e.g., changes in sleep efficiency, REM latency, arousals, or cyclic alternating patterns) and behavioral symptoms or parental stress profiles.

Ultimately, the findings are expected to contribute to the development of more precise and individualized diagnostic frameworks, as well as inform evidence-based therapeutic strategies. These insights could be of considerable clinical relevance, given the high prevalence of sleep disorders in the ASD population and their significant impact on daytime functioning, emotional regulation, and family quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disorder (Disorder) Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autism spectrum disorder

Subjects with SRS-2 positive screening and confirmed by ADOS-2 evaluation

Questionnaires about autism spectrum disorders and sleep and PSG.

Intervention Type DIAGNOSTIC_TEST

Recruitment of subjects with autism spectrum disorder at all developmental ages and of all severity levels.

ADOS-2, ADI-R, SRS-2, PSG

Intervention Type DIAGNOSTIC_TEST

Recruitment of subjects with autism spectrum disorder at all developmental ages and all severity levels.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires about autism spectrum disorders and sleep and PSG.

Recruitment of subjects with autism spectrum disorder at all developmental ages and of all severity levels.

Intervention Type DIAGNOSTIC_TEST

ADOS-2, ADI-R, SRS-2, PSG

Recruitment of subjects with autism spectrum disorder at all developmental ages and all severity levels.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Autism Spectrum Disorder
* Age: 3-18 years
* Sex: Both male and female
* Individuals with Autism Spectrum Disorder, including both verbal and non-verbal subjects
* Individuals with Autism Spectrum Disorder, with or without a comorbid genetic syndrome or other neurodevelopmental disorders

Exclusion Criteria

* Neuropsychiatric disorders other than autism
* Epilepsy
* Age under 3 years or over 18 years
* Comorbidity with another severe psychiatric disorder (e.g., psychosis, schizophrenia)
Minimum Eligible Age

3 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Campania Luigi Vanvitelli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marco Carotenuto

Full Professor of Child Neuropsychiatry

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Campania Luigi Vanvitelli

Napoli, Napoli, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Marotta R, Risoleo MC, Messina G, Parisi L, Carotenuto M, Vetri L, Roccella M. The Neurochemistry of Autism. Brain Sci. 2020 Mar 13;10(3):163. doi: 10.3390/brainsci10030163.

Reference Type BACKGROUND
PMID: 32182969 (View on PubMed)

Voci A, Mazzone L, De Stefano D, Valeriani M, Bruni O, Moavero R. Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series. J Clin Sleep Med. 2024 Mar 1;20(3):427-432. doi: 10.5664/jcsm.10902.

Reference Type BACKGROUND
PMID: 37909101 (View on PubMed)

Belli A, Breda M, Di Maggio C, Esposito D, Marcucci L, Bruni O. Children with neurodevelopmental disorders: how do they sleep? Curr Opin Psychiatry. 2022 Sep 1;35(5):345-351. doi: 10.1097/YCO.0000000000000790. Epub 2022 Feb 15.

Reference Type BACKGROUND
PMID: 35165244 (View on PubMed)

Bernardi K, Prono F, Bruni G, Panerai S, Ferri R, Bruni O. Sleep disturbances in subjects with autism spectrum disorder: A parental perspective. Sleep Med. 2023 Oct;110:220-224. doi: 10.1016/j.sleep.2023.08.020. Epub 2023 Aug 23.

Reference Type BACKGROUND
PMID: 37643569 (View on PubMed)

Bruni O, Breda M, Mammarella V, Mogavero MP, Ferri R. Sleep and circadian disturbances in children with neurodevelopmental disorders. Nat Rev Neurol. 2025 Feb;21(2):103-120. doi: 10.1038/s41582-024-01052-9. Epub 2025 Jan 8.

Reference Type BACKGROUND
PMID: 39779841 (View on PubMed)

Scahill L, Johnson CR, Wenzell ML, Barto LM, Mulligan A, Williams AT, Johnson LM, Gillespie SE, Lecavalier L. Clinical and Demographic Correlates of Insomnia Symptoms in Children with Autism Spectrum Disorder. J Autism Dev Disord. 2025 Jul 31. doi: 10.1007/s10803-025-06944-3. Online ahead of print. No abstract available.

Reference Type BACKGROUND
PMID: 40742672 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

217

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autism Oxytocin Brain Project
NCT03033784 COMPLETED PHASE2